infectiuo Flashcards

1
Q

effect of virus on the lung

A

cellular inflammation
local immune memory
loss of chemoreceptors
poor barrier to hygiene
promote bacterial growth as immune system fights virus cant fight bacteria
loss of cilia - less able to clear bacteria
mediator release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

microbiomes

A

in lung and pharynx as dense as on skin

these bacteria cause pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

common cold agents

A
rhinovirus 
coronaviruses 
influenza viruses 
parainfluenza viruses 
resp syncytial virus 
adenovirus
enteroviruses
mycoplasma 
chlamydia 
exchange between hosts through air 
virus previously been GI - evolved because of ease of transmission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

community acquired pneumonia

A

eading infectious cause of hospitalisation and deaths in US adults
exceeds $1obillion annually
cooperation between bacteria and virus in the disease - influenza A and B, and resp syncytial virus present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what causes hospital acquired pneumonia

A
staphylococcus aureus 28% 
pseudomonas aeruginosa 21.8%
klebsiella species 9.8%
E coli 6.9%
Acinetobacter 6.8%
Enterobacter 6.3%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what causes CAP

A

strep pneumonia - classic presentation: cough, rusty sputum, cold sore
myxoplasma pneumonia - incidious atypical disease
staph aureus - people who are sick in other ways/immuneparetic
chlamidophilia pneumoniae - rare
haemophilus influenza - people with asthma, colo9nised with pneumonia after a viral infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

typical V atypical pathogens in CAP

A

typical - streptococcus pneumoniae, haemophilus influenzae, Moraxella catarrhalis
atypical pathogens - mycoplasma pneumoniae, chlamysia pneumonae, legionella pneuomophilia
atypical not covered by penicillins - need additional agents eg macrolides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

pneumonia and age

A

after 70 the presenting rate of pneumonia increases
but younger eg 60, there is a higher fatality rate in the people who get the condition
age risk factor because of susceptibility to the virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

risk factor for pneumonia

A
age <2, >65
smoking 
alcohol 
contact with children <15 
poverty and overcrowding - confound with passive smoking 
inhaled corticosteroids
immunosuppressants - steroids
proton pump inhibitors 
COPD 
asthma
heart disease
liver disease
DM 
HIV 
malignancy
hyposplenism 
complement or Ig deficiencies
risk factors for aspiration 
previous pneumonia 
geo variations 
animal
healthcare contacts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

symptoms of pneumonia

A
hypoxic
febrile - temp 38degrees
crepitations - crackle in lungs 
new respiratory symptoms orb signs 
pleuritic chest pain 
confused 
new X ray changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is pneumonia a disease of

A

interstitium

affect GE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

investigations for CAP

A

chest xray - could be pneumponia even if normal
blood test - full count - see if responding should be neutrophils and WBC, check urea electrolytes liver func and C reactive protein - check for risk of combined disease part of the septic syndrome
arterial blood gases - how sevele lung desaturation is and look for lactic acidosis
microbiological investigations - sputum culture, blood culture, urine antigen tests for legionella pneumophilia and streptococcus pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

guidelines for diagnosing pneumonia

A

acute lower resp tract syndrome
new focal chest sign and signs on X ray
>1 systemic feature eg fever, shiver ache, pain, temp> 38degrees
no other explanation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CRB 65 severity score

A
1 point for every feature 
confusion 
resp rate >=30/min
SBP <90 or DBP <=60mmHg 
>=65years
0 = low severity - home and AB 
12 - moderate, consider hospital 
3-4 high severity - urgent hospital, empirical AB if life threatening, may need ventilation
consider social setting and home support
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

supportive therapy for pneumonia

A
oxygen - for hypoxia 
fluids for dehydration 
analgia for pain 
nebulised saline - may help expectoration 
chest physiotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

AB therapy that is given for pneumonia

A

low severity - amoxicillin with doxycycline - effective and low side effect profile - especially with haemophilus
severe - benzylpenicillin IV or telcoplanin and clathiro PO
for 5-7 days
7-14 days for atypicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

time frame of delivery of AB for pneumonia

A

crucial
in severe AB delivered as soon as possible
for every hour dekay in septic shock - chance of survival reduced by 7.9%
duration 1wk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Influenza pandemic

A

helitrope hue
could detect bacteria - haemophilus influenza
show association with bacterial colonisation and pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

treatment for flu

A

Tamiflu and IV clarithromycin early

otherwise need prol0ngued ventilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

signs of flu

A
fever 
cough 
aches 
breathless at rest 
nausea 
increased SOB at rest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what causes severe disease

A

RNA sequence
viral load
DNA
environment
cause epithelial damage and storm of mediators
secondary bacteria infection
from host and virus - host genetics - variation in IFITN3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what causes sever flu

A
highly pathogenic strains - zoonotic 
ijnnate immune deficiency - IFITN3 
local absence of B cells 
absence of T cells 
frail elderly 
COPD 
asthma 
DM 
obesity 
pregnancy 
V young
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

global changes in RSV and flu prevalence per month

A

swing between N and S hemispheres

RSV slightly predates flu

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

influenza

A
no reinfection by the same strain 
imperfect vaccines 
homotypic immunity 
vaccine induced immunity fades
annual vaccine required 
perfect virus - runs away from immune system by evolving
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

RSV

A
infectious form is filamentus 
recurrent reinfection with similar strains 
controls the immune system 
no vaccine 
poor immunogenity
vaccine enhanced disease 
researched field 
relatively stable but does evolve - now have niche strains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

RSV broncholitis

A

caused by RSV
affects babies
commonest cause of admission in infancy in developed countries
1/3 beds in winter
airways full of inflammatory cells - blocked - stop airflow

27
Q

RSV broncholitis clinical features

A
chest wall retractions 
tachypnea with apneic episodes
expiratory wheezing 
prolonged expiration rates and rhonchi 
croupy cough
hypoxemia and cyanosis 
nasal flaring
28
Q

Age and RSV

A

children - infantile bronchitis - causally related to wheeze, older siblings spreaders
transmitted from children to older people
when they get admitted already had it for 3wks
when tested for it its already gone
old people - major cause of progressive lung disease and deaths
adults - colds, transmitters but not severe

29
Q

RSV vaccine

A

nasal spray not immunogenic enough
novavex - injected nanoparticle into pregnant women, effective against severe disease but not common - overnight drop in stock market

30
Q

symptoms and viral load for RSV and flu

A

RSV more delayed disease

communication between virus and the mucosa

31
Q

bacterial loads in COPD patients infected with rhinovirus

A

bacteria level climb with virus level

32
Q

relationship between bacteria and virus

A

lung not sterile - contain organisms that are likely to casue pneumonia
bacterial infection likely to be caused by viral pathogen

33
Q

location of airway diseases

A

allergic rhinitis - upper airways
bronchi - asthma
allergic alveolitis - alveoli

34
Q

immunological hypersensitivity

A

IgE mediated - atopic diseases, hayfever, eczema and asthma

non IgE mediated - allergic diseases - farmers lung

35
Q

non-immunological hypersensitivity

A

intolerance
enzyme deficiency - lactase DH
pharmacological - aspirin hypersensitivity

36
Q

allergic rhinitis

A
hayfever 
25% prevalence in UK 
40% world wide 
seasonal allergy 
12-15% children 
effect on exams - reduced QoL 
polysensitised because of travel 
sleep deprivation 
reduced productivity 
runny nose, sneeze, congestion, red and watery eyes
37
Q

allergy

A

exaggerated immunological response to allergen - inhaled, injected, swallowed, in contact with skin/eye
mechanism
in some diseases some of the time, others all the time

38
Q

mechanism of allergy

A

biophysical response
early hypersensitive response - 5-30mins eg sneeze, mast cells
late hypersensitivity response - 8-12hrs - nasal congestion, eosinophils make IL 5 - recruit T cells

39
Q

T helper type 1

A
for virus, bacteria, fungi, protozoa 
Th17 cells 
NK cells 
cytotoxic t cells 
IgM 
IgA 
IgG
40
Q

T helper type 2

A
for helminths and ectoparasites (ticks) 
IgE 
IgG1
innate lymphoid cells 
eosinophils
mast cells 
basophils 
activated macrophages
41
Q

pathophysiology of allergic rhinitis

A

sensitisation then subsequent exposure
nasal epi already damaged
allergen seep in
DC capture allergen
migrate to lymph node
stimulate ILC2 cells - produce IL5 and IL13
help T cell prime and mature to T follicular helper cell
TfH prime B cell for proliferation and differentiation
into plasma cells
make IgE
sensitise mast and basophils in target by cross linking them
subsequent exposure = degranulation

42
Q

Type 2 immune response

A

IL4
Il5 - survival factor for eosinophils
IL13
cytokines

43
Q

atopy

A

hereditary predisposition to produce IgE Ab agaiunst common env allergens
atopic disease: allergic rhinitis, asthma, atopic eczema
characterised by Th2 cells and eosinophils
can be atopic but not allergic - don’t express symptoms

44
Q

allergic march

A

through age - asthma increase gradually

hayfever - exposed to 3 seasons before prevalent

45
Q

causes of allergic rhinitis and asthma

A
house dust mite
cats 
dogs
Alternaria 
cockroach 
horses
46
Q

asthma

A

effects 8-12% population
eosinophil/neutrophil
L5
inflamed lung from allergen and infiltration of cells

47
Q

phenotypes of asthma

A

based on control and severity:
intermnittent, mild, allergy freq important
presistant, manageable allergy often important
chronic, severe, uncontrolled
based on endotype or endo-phenotype:
allergic, atopic, eosinophilic
neutrophilic

48
Q

endotype

A

subtype of condition

defined by distinct pathophysiological mech

49
Q

extrinsic allergic alveolitis

A
0.1% pop
exposure to allergens 
allergen captured by Ab 
complement, chemotactic factors, neutrophils, macrophages, fibroblasts 
hypersensitivity response 
cause inf response
50
Q

examples of extrinsic allergic alveolitis

A

farmers lung - mouldy hay
bird fanciers lung - bird dropping
air conditioners lung - air conditioner mould
mushroom workers lung - mushroom compost
coffee workers lung - unroasted coffee beans
millers lung- infested flour
hot tub lung - bacterial contamination

51
Q

treatment of allergic disease

A

allergen avoidance
anti-allergic med - antihistamine(80%pop)/nasal steroids
immunotherapy - desensitisation/hyposensitisation

52
Q

prevalence of allergic rhinitis

A

ww 40%
uk 23%
Belgium and france highest

53
Q

what does treatment of allergic rhinitis depend on

A

type of condition
mild intermittent - start H1 blocker, allergen avoidance
mod/severe int - start intranasal and immunotherapy
mild persistent
mod/severe persistent

54
Q

noon and freeman

A

mash up pollen
treat hayfever by immunisation
patients did better

55
Q

investigating immunotherapy

A

RCT
practicality - incremental dose over 12 wks
maintenance over 3yrs
only can demonstrate if good pollen season

56
Q

types of allergen immunotherapy

A

tablet - for 3yrs daily - compliance issue

subcutaneous - have to monitored for a day, exposed to allergen - not risk free

57
Q

allergen immunotherapy +ve

A

effective

long lasting

58
Q

allergen IT -ve

A

occasional severe rn
time consuming
standardisation problems

59
Q

mechanism of IT

A

alter DC
make IL 10 and IL 27 - shift to type 1 response - immune deviation
interferon gamma produced
Treg cells produced - suppress proallergic response and casue production og IgG - capture antigen
IgG compete with IgE - stop IgE fascilitating cross link between basophils and eosinophil
remove IgG - remove response
add it back - response returns

60
Q

studies for IT

A

suppression of TH2 for yr 1 and 2, symptoms and TH2 appear again in 3rd yr
measure IL5 - type 2, Inf gamma - type 1 - evaluate immune deviation
measure IL 10 - measure Trg response
take 12 moths for immune deviation
3month for Treg
biopsy of allergic area - see T cell in mucosa
correlation between symptom, cell and cytokine to see if there is a correlation
2 months ago

61
Q

IL 35

A

member of IL12 superfamily
bind to P35, Ebi3
receptor - IL12Rbeta2, gp130
STAT4 and STAT1
suppress type 2 response
supress T cekll response - so late allwergic response
suppress B cell response making IgE - stop basophil and mast cell bind - stop early phase
make IL10 - suppress cytokines, monocytes making TNF-a, Th2, Th1 diff, Tr1 induction, IgE. induce IgG and Foxp3+ Treg cells

62
Q

antibodies

A

immunological marker in term sof exposure
produced by Breg
measure func of Ab
IgG compete with OgE
biomarker of compliance and clinical response
have IT = more IgG

63
Q

how to B cells and T cells communicate

A

FceRII (CD23) on B cell bind to allergen and IgE complex
internalised
present as MHC class 2 to T cell
not when IgG compete